| Financial Year |
March 31 2023 |
| Monetary Funds |
518,575,655.40 |
| Held-for-trading Financial Assets |
139,000,000.00 |
| Notes Receivable |
2,205,932.20 |
| Accounts Receivable |
159,660,473.70 |
| Advances to Suppliers |
23,004,491.06 |
| Other Receivables |
14,115,068.37 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
171,753,593.50 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
14,554,357.59 |
| Total Current Assets |
1,062,338,678.10 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
4,364,673.62 |
| Investment Properties |
-- |
| Fixed Assetes |
132,928,722.34 |
| Under-construction Projects |
2,352,725.51 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
18,642,607.18 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
2,883,937.19 |
| Deferred Income Tax Assets |
9,443,647.93 |
| Other Non-Current Assets |
49,554,620.05 |
| Sub-Total of Non-Current Assets |
242,022,621.28 |
| Total Assets |
1,304,361,299.38 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
6,925,984.90 |
| Accounts Payable |
46,455,378.88 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
33,407,756.50 |
| Taxes Payable |
593,348.81 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
32,110,780.43 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
8,373,194.04 |
| Other Current Liabilities |
6,893,973.58 |
| Sub-Total of Current Liabilities |
187,178,213.34 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
24,290,024.80 |
| Total Liabilities |
211,468,238.14 |
| Paid-In Capital(Or Share Stock) |
142,711,301.00 |
| Capital Surplus |
399,709,113.93 |
| Surplus Reserve |
69,786,244.78 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
480,644,890.74 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,092,893,061.24 |
| Owner's Equity（Stockholder's Equity） |
1,092,893,061.24 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,304,361,299.38 |
